# Escalon Medical Corp > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Escalon Medical Corp). ## Overview Escalon Medical Corp. develops, manufactures, markets, and distributes ophthalmic medical devices and related products for eye-care procedures and diagnostics. Its portfolio includes ultrasound systems for biometric and diagnostic use, disposable surgical packs for vitreoretinal surgery, and the AXIS image management system for ophthalmic imaging workflows. ## Products & services • Ophthalmic ultrasound systems for A-scan and B-scan diagnostics • Disposable surgical packs for vitreoretinal surgery • Silicone oil injection/extraction packs • AXIS Image Management system for ophthalmic images • Service, repair, and support for installed products - **Ophthalmic ultrasound systems** (45%) — A-Scan and B-Scan ultrasound devices and related software used for eye diagnostics and biometric measurements. - **Ophthalmic surgical disposables** (35%) — Disposable surgical packs used in vitreoretinal surgery, including silicone oil handling packs. - **Image management software** (10%) — AXIS Image Management system for storing and accessing ophthalmic diagnostic images through a web browser. - **Service and support** (10%) — Repairs, warranties, and remote support for ultrasound, imaging, and surgical products. - Ophthalmic ultrasound systems for biometric and diagnostic applications - A-Scan and B-Scan devices used to measure eye structure - Disposable surgical packs for vitreoretinal surgery - Silicone oil injection and extraction packs - AXIS Image Management for ophthalmic diagnostic images - Product repair, warranty, and remote support services ## Customers Escalon sells primarily to medical institutions and eye-care providers that need diagnostic equipment, surgical consumables, and image management tools for ophthalmology workflows. Its customer base is served through independent sales representatives, distributors, and direct sales employees, which suggests a mix of hospital, clinic, and specialty practice end users. The company also supports installed customers with repair and service, which helps retain recurring relationships after the initial sale. - **Ophthalmic hospitals and clinics** (primary) — Buy ultrasound systems and image management tools to diagnose and monitor eye conditions. - **Vitreoretinal surgeons** (primary) — Buy disposable surgical packs and silicone oil handling packs for procedure-specific use. - **Distributors and independent reps** (secondary) — Place products into local healthcare markets and expand reach without a large direct field force. - **Existing installed-base customers** (secondary) — Purchase repairs, service, and replacement support for previously installed systems. - Hospitals and medical institutions buying ophthalmic diagnostic systems - Eye surgeons and vitreoretinal specialists using disposable surgical packs - Ophthalmology clinics needing imaging and workflow software - Distributors and sales reps that place products into local markets - Installed-base customers that need repairs, warranties, and support ## Geography Escalon sells throughout the United States and internationally, with 56.0% of fiscal 2025 revenue generated domestically and 44.0% from foreign markets. The company manufactures and assembles ophthalmic surgical products in New Berlin, Wisconsin, and designs, assembles, and services ultrasound products in Lake Success, New York, so its operating footprint is concentrated in the U.S. while sales are globally distributed. - **United States** (56%) — Fiscal 2025 domestic revenue share - **Foreign** (44%) — Fiscal 2025 international revenue share - United States generated 56.0% of fiscal 2025 revenue - Foreign markets generated 44.0% of fiscal 2025 revenue - New Berlin, Wisconsin handles ophthalmic surgical assembly and distribution - Lake Success, New York handles ultrasound design, assembly, and service - CE Mark supports sales in Europe and other international markets ## Strategy Escalon’s strategy centers on refreshing ophthalmic products, supporting its installed base, and using regulatory clearances such as FDA registration and CE Mark to sell into more markets. The company also appears focused on maintaining a broad product mix across ultrasound, surgical disposables, and imaging software to reduce reliance on any single product line. - **Product development and enhancement** (short-term) — R&D is tied to new and improved ophthalmic products that can drive adoption and offset mature product pressure. - **International market access** (medium-term) — CE Mark and other clearances allow the company to sell beyond the U.S. and diversify demand. - **Operational support and service retention** (medium-term) — Repairs, warranties, and remote support help preserve installed-base relationships and recurring revenue. - Develop new or enhanced ophthalmic products through ongoing R&D - Support and expand the AXIS image management platform - Maintain FDA and CE Mark compliance to access U.S. and foreign markets - Use distributors and direct sales to broaden market reach - Improve product mix and service support to stabilize revenue ## Risks Escalon faces meaningful execution and balance-sheet risk because it has a history of operating losses and management has disclosed substantial doubt about going concern. Its business is also exposed to regulatory, product liability, cybersecurity, and supply-chain risks, all of which can disrupt sales or raise costs in a small medical-device platform. Dependence on a few customers and suppliers adds concentration risk to an already narrow product base. - **Going concern and liquidity pressure** [critical] — The company has a history of operating losses and disclosed substantial doubt about continuing as a going concern. - **Regulatory approval and compliance** [high] — Medical devices require FDA and foreign clearances, and changes in rules can delay launches or restrict sales. - **Product liability** [high] — Surgical and diagnostic products can create claims if defects or performance issues occur. - **Cybersecurity and data privacy** [medium] — The company uses internet-based systems and stores confidential customer and employee data. - **Customer and supplier concentration** [high] — A small number of customers and suppliers can materially affect sales, receivables, and production continuity. - Going concern risk from historical losses and limited liquidity - FDA and foreign regulatory risk can delay or block product sales - Product liability claims can arise from surgical and diagnostic devices - Cybersecurity incidents could disrupt operations and expose data - Customer and supplier concentration can amplify revenue and supply shocks ## Accounting Escalon’s reported results are sensitive to revenue mix between products and service plans, as well as quarter-to-quarter fluctuations in product introductions and customer ordering patterns. Investors should also watch estimates tied to going concern assessment, receivables collectability, inventory, warranty obligations, and lease accounting, since the company operates with a small base and concentrated counterparties. - **Revenue mix and timing** — Affects quarterly comparability and gross margin - **Going concern and liquidity estimates** — Can influence disclosures and valuation assumptions - **Allowance for doubtful accounts** — Affects net revenue and working capital - **Inventory and warranty-related estimates** — Affects cost of revenue and liabilities - **Lease accounting** — Affects balance sheet assets and liabilities - Revenue mix between products and service plans affects margin and comparability - Quarterly fluctuations can be driven by product launches and order timing - Going concern assessment depends on liquidity and future operating performance - Receivables and supplier balances are concentrated, affecting credit and payable estimates - Lease accounting matters because the company uses leased facilities in Wisconsin and New York --- *Last updated: 2026-04-28T20:03:39.549023+00:00*